Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pregnancy Medication Market
Pregnancy Medication Market Size
- Report ID: GMI5385
- Published Date: Oct 2022
- Report Format: PDF
Pregnancy Medication Market Size
Pregnancy Medication Market size was valued at over USD 33 billion in 2022 and is poised to witness 13% CAGR from 2023 to 2032.
Rapid development in incidences of pregnancy-associated complications is expected to drive the demand for pregnancy medication. Based on estimates by the World Health Organization, every day, almost 800 women worldwide die due to complications during childbirth. These intricacies are 36 times more prevalent in developing economies than in developed countries. The alarming progress in childbirth-related complications can be attributed to improper dietary habits, physical inactivity, and the rising adoption of a sedentary lifestyle.
Consumption of unhealthy food during pregnancy can increase the risk of developing various long-term irreversible health issues. These may range from high blood pressure, cholesterol, heart diseases, and type 2 diabetes to defective childbirth. The rapid inclination toward maintaining a proper nutritional diet rich in all micro and macronutrients to support the health of the mother and the fetus will create positive growth prospects for the pregnancy medication industry.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Pregnancy Medication Market Size in 2022: | 33 Billion (USD) |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 13% |
| 2032 Value Projection: | 112 Billion (USD) |
| Historical Data for: | 2017 to 2022 |
| No. of Pages: | 255 |
| Tables, Charts & Figures: | 261 |
| Segments covered: | Drug Class, Pregnancy Stage, Distribution Channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Pregnancy Medication Market Scope
